US Patent 7572949 SKN-1 and GSK-3 genes and proteins
Patent 7572949 was granted and assigned to Immune Disease Institute, Inc. on August, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jae Hyung An0
T. Keith Blackwell0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+250 characters)
Article
Patent abstract
The present invention relates, in part, to the C. elegans SKN-1 gene and protein (a transcription factor), and target genes thereof. The invention includes various therapeutic methods and screening methods for identifying antioxidants.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07572949 SKN-1 and GSK-3 genes and proteins US Patent 7572949 SKN-1 and GSK-3 genes and proteins
Infobox
Patent Number
07572949
Patent Number
7572949
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07572949 SKN-1 and GSK-3 genes and proteins
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07572949
Date of patent
August 11, 2009
Patent application number
10560563
Date Filed
June 14, 2004
Patent primary examiner
Find more entities like US Patent 7572949 SKN-1 and GSK-3 genes and proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
